Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Penka · SciRah

Researcher profile · Semantic Scholar

M. Penka

Share profile

M. Penka — researcher profile on SciRah

h-index: 23
Works: 251
Citations: 2,084

Most-cited papers

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.
H. Gisslinger, M. Gotic, J. Hołowiecki, M. Penka +4 more
2013Blood308 citations Open access
Semantic Scholar
Increased T Regulatory Cells Are Associated with Adverse Clinical Features and Predict Progression in Multiple Myeloma
Karthick Raja Muthu Raja, L. Říhová, L. Zahradová, M. Klincová +2 more
2012PLoS ONE121 citations Open access
Semantic Scholar
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status
B. Kubešová, Š. Pavlová, J. Malčíková, J. Kabáthová +16 more
2017Leukemia74 citations Open access
Semantic Scholar
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma
T. Jelínek, R. Bezděková, D. Žihala, T. Ševčíková +26 more
2022Journal of Clinical Oncology65 citations Open access
Semantic Scholar
Cytogenetics in multiple myeloma patients progressing into extramedullary disease
L. Besse, L. Sedlaříková, H. Grešliková, R. Kupská +9 more
2016European Journal of Haematology58 citations
Semantic Scholar
Circulating exosomal long noncoding RNA PRINS—First findings in monoclonal gammopathies
L. Sedlaříková, B. Bollová, L. Radová, L. Brožová +8 more
2018Hematological Oncology49 citations Open access
Semantic Scholar
Deregulated expression of long non‐coding RNA UCA1 in multiple myeloma
L. Sedlaříková, B. Gromesová, Veronika Kubaczková, L. Radová +14 more
2017European Journal of Haematology46 citations
Semantic Scholar
Increased mean platelet volume and immature platelet fraction as potential predictors of thrombotic complications in BCR/ABL-negative myeloproliferative neoplasms
J. Kissová, A. Bulíková, P. Ovesná, L. Bourková +1 more
2014International journal of hematology34 citations
Semantic Scholar
Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients.
J. Halamkova, I. Kišš, Z. Pavlovský, J. Tomášek +11 more
2011Neoplasma (Bratislava)29 citations
Semantic Scholar
Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.
J. Smetana, K. Beránková, R. Zaoralova, P. Němec +17 more
2013Clinical Lymphoma, Myeloma & Leukemia26 citations Open access
Semantic Scholar
Thrombosis in thrombocythemic Ph‐ myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide
J. Schwarz, P. Ovesná, O. Černá, J. Kissová +9 more
2016European Journal of Haematology24 citations Open access
Semantic Scholar
Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma
L. Besse, L. Sedlaříková, F. Kryukov, J. Nekvindová +10 more
2015PLoS ONE24 citations Open access
Semantic Scholar
Second malignancies in philadelphia-negative myeloproliferative neoplasms-single-center experience.
J. Kissová, P. Ovesná, M. Penka, A. Bulíková +1 more
2014Anticancer Research24 citations
Semantic Scholar
Clinical relevance of uPA, uPAR, PAI 1 and PAI 2 tissue expression and plasma PAI 1 level in colorectal carcinoma patients.
J. Halamkova, I. Kišš, Z. Pavlovský, Jirí Jarkovský +7 more
2011Hepato-Gastroenterology21 citations
Semantic Scholar
Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia
R. Bezděková, T. Jelínek, R. Králová, M. Štork +12 more
2021British Journal of Haematology18 citations Open access
Semantic Scholar
Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience
J. Kissová, P. Ovesná, A. Bulíková, J. Zavřelová +1 more
2015Blood Coagulation and Fibrinolysis18 citations
Semantic Scholar
Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test
J. Michiels, P. Smejkal, M. Penka, A. Bátorová +4 more
2017Clinical and applied thrombosis/hemostasis16 citations Open access
Semantic Scholar
Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
Andrea Knight, L. Říhová, R. Králová, M. Penka +4 more
2021Journal of Clinical Medicine14 citations Open access
Semantic Scholar
Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide.
M. Almáši, S. Ševčíková, O. Slabý, Petra Kaisarová +8 more
2011Clinical Lymphoma, Myeloma & Leukemia14 citations
Semantic Scholar
Recommendations for the diagnosis and treatment of patients with polycythaemia vera
A. Hatalova, J. Schwarz, M. Gotic, M. Penka +15 more
2018European Journal of Haematology13 citations
Semantic Scholar
[Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
J. Schwarz, M. Penka, V. Campr, D. Pospíšilová +12 more
2011Vnitrni lekarstvi13 citations
Semantic Scholar
Pharmacokinetic Comparison of Subcutaneous and Intravenous Nadroparin Administration for Thromboprophylaxis in Critically Ill Patients on Vasopressors
Radek Cihlář, V. Šrámek, A. Papiez, M. Penka +1 more
2019Pharmacology12 citations
Semantic Scholar
Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic.
P. Salaj, M. Penka, P. Smejkal, V. Geierová +6 more
2012Thrombosis Research12 citations
Semantic Scholar
Increasing procoagulant activity of circulating microparticles in patients living with HIV.
S. Snopkova, M. Matýšková, K. Havlickova, Jirí Jarkovský +5 more
2020Médecine et maladies infectieuses9 citations
Semantic Scholar
Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study
I. Vangenechten, P. Smejkal, O. Zapletal, J. Michiels +5 more
2019Thrombosis and Haemostasis9 citations
Semantic Scholar
Ph− myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide
M. Kostal, J. Schwarz, P. Ovesná, M. Penka +1 more
2020Journal of Thrombosis and Thrombolysis8 citations
Semantic Scholar
Inhibitors incidence rate in Czech previously untreated patients with haemophilia A has not increased since introduction of recombinant factor VIII treatment in 2003
J. Blatný, V. Komrska, B. Blažek, M. Penka +1 more
2015Blood Coagulation and Fibrinolysis8 citations
Semantic Scholar
Analysis of von Willebrand Disease in the “Heart of Europe”
I. Vangenechten, P. Smejkal, J. Zavřelová, O. Zapletal +8 more
2022TH Open7 citations Open access
Semantic Scholar
Analysis of B-cell subpopulations in monoclonal gammopathies.
P. Všianská, L. Říhová, T. Varmužová, R. Suská +7 more
2015Clinical Lymphoma, Myeloma & Leukemia7 citations Open access
Semantic Scholar
Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry.
P. Salaj, R. Kubeš, P. Cetkovský, Irena Čápová +4 more
2014Thrombosis Research6 citations
Semantic Scholar
Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patients.
J. Halamkova, I. Kišš, Z. Pavlovský, J. Tomášek +12 more
2013Neoplasma (Bratislava)5 citations Open access
Semantic Scholar
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma.
P. Kessler, L. Pour, E. Gregora, M. Zemanova +21 more
2011Klinicka onkologie5 citations
Semantic Scholar
[The current role of warfarin].
Jana Michalcova, A. Bulíková, J. Zavřelová, Marie Prudková +1 more
2018Vnitrni lekarstvi4 citations
Semantic Scholar
The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms
Mohamed Hussam Aswad, J. Kissová, P. Ovesná, L. Říhová +1 more
2021In Vivo3 citations Open access
Semantic Scholar
Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms.
Mohamed Hussam Aswad, J. Kissová, P. Ovesná, M. Penka
2021Neoplasma (Bratislava)3 citations Open access
Semantic Scholar
[Medication adherence to non-vitamin K antagonist oral anticoagulants at non-valvular atrial fibrillation - the literature review].
S. Dvořáčková, K. Ládová, J. Malý, J. Kolář +1 more
2018Vnitrni lekarstvi3 citations
Semantic Scholar
Activity of aldehyde dehydrogenase in B‐cell and plasma cell subsets of monoclonal gammopathy patients and healthy donors
P. Všianská, R. Bezděková, F. Kryukov, M. Almáši +4 more
2017European Journal of Haematology3 citations
Semantic Scholar
Identification of Phenotype Profile Related to the Extramedullary Involvement in Multiple Myeloma Relapse
L. Říhová, P. Všianská, R. Bezděková, Z. Adam +5 more
20163 citations Open access
Semantic Scholar
[Summary of recommendations for the diagnosis and therapy of BCR/ABL-negative myeloproliferation of the Czech Working Group for Ph-negative myeloproliferative disease (CZEMP) of the Czech Hematologic Society CLS JEP ].
M. Penka, J. Schwarz, V. Campr, D. Pospíšilová +12 more
2012Vnitrni lekarstvi3 citations
Semantic Scholar
Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the dia gnosis and treatment of patients with haemophilia, 3rd edition, year 2021
P. Smejkal, J. Blatný, Z. Hajšmanová, A. Hluší +3 more
20212 citations
Semantic Scholar
Pembrolizumab-induced hypothyreosis and subcutaneous bleeding.
P. Polák, Jana Špeldová, M. Bratová, J. Zavřelová +1 more
2021Vnitrni lekarstvi2 citations Open access
Semantic Scholar
Circulating Plasma Cells Are the Most Powerful Prognostic Marker in Transplant Ineligible Multiple Myeloma with 2% As a New Cut-Off for Primary Plasma Cell Leukemia
T. Jelínek, R. Bezděková, D. Žihala, T. Ševčíková +13 more
2021Blood2 citations Open access
Semantic Scholar
Heparin-induced thrombocytopenia: a case report and literature overview.
P. Polák, Y. Kaloudová, H. Krupicová, P. Coufal +9 more
2020Vnitrni lekarstvi2 citations Open access
Semantic Scholar
Spontaneous retroperitoneal hematoma - our experience with surgical approach.
L. Mitas, T. Nevrtal, L. Kunovský, Z. Kala +5 more
2019Rozhledy v Chirurgii2 citations
Semantic Scholar
Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients.
M. Almáši, L. Besse, L. Brožová, Jirí Jarkovský +10 more
2018Klinicka onkologie2 citations Open access
Semantic Scholar
Determination of Two Rapid Von Willebrand Factor (VWF) Activity assays VWF: Gpibm and VWF: Gpibr in Well Defined Von Willebrand Disease Patients Using a Complete Set of Classical and Sensitive VWF Assays
J. Michiels, P. Smejkal, O. Zapletal, M. Penka +6 more
20182 citations
Semantic Scholar
Idarucizumab (Praxbind®) – studie RE-VERSE AD
M. Penka, Jana Michalcova, J. Zavřelová, Marie Prudková +1 more
20162 citations
Semantic Scholar
Deregulated Expression of Long Non-Coding RNAs UCA1, NEAT1 and BDNF-As in Multiple Myeloma
L. Sedlaříková, B. Gromesová, J. Filipová, Veronika Kubaczková +8 more
20162 citations
Semantic Scholar
Changing insights in the diagnosis and classification of autosomal recessive and dominant von Willebrand diseases 1980-2015
J. Michiels, A. Bátorová, Tatiana Prigancová, P. Smejkal +3 more
20162 citations Open access
Semantic Scholar
[Disturbances of hemostasis in sepsis].
J. Novotný, M. Penka
2012Vnitrni lekarstvi2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Hájek×16
Invite
R. Hájek — researcher profile on SciRah
L. Pour×15
Invite
L. Pour — researcher profile on SciRah
S. Ševčíková×12
Invite
S. Ševčíková — researcher profile on SciRah
J. Zavřelová×11
Invite
J. Zavřelová — researcher profile on SciRah

×10

Invite

L. Říhová — researcher profile on SciRah

M. Almáši×10

Invite

M. Almáši — researcher profile on SciRah

Invite

P. Ovesná — researcher profile on SciRah

Invite

J. Kissová — researcher profile on SciRah

Invite

Z. Adam — researcher profile on SciRah

Jirí Jarkovský×9

Invite

Jirí Jarkovský — researcher profile on SciRah

R. Bezděková×8

Invite

R. Bezděková — researcher profile on SciRah

Invite

P. Smejkal — researcher profile on SciRah